Durham P L, Wohlford-Lenane C L, Snyder J M
Department of Anatomy, University of Iowa College of Medicine, Iowa City 52245.
Anat Rec. 1993 Nov;237(3):365-77. doi: 10.1002/ar.1092370310.
The effects of a maternally administered synthetic glucocorticoid, betamethasone, on the levels of mRNA for the surfactant proteins SP-A, SP-B, and SP-C and on the levels of SP-A protein were investigated in day 27 gestational age rabbit fetal lung tissue. Betamethasone administration to the pregnant rabbit caused approximately a twofold increase in the fetal lung level of SP-A protein and a threefold increase in fetal lung SP-A mRNA levels when compared to levels in fetuses obtained from saline-treated or uninjected animals. SP-B mRNA was increased fourfold in fetal lung tissue obtained from glucocorticoid-treated pregnant does when compared to levels in fetuses of uninjected pregnant does. However, SP-B mRNA levels in fetal lung tissue from saline-injected controls were also significantly elevated, approximately twofold, when compared to fetal lung SP-B mRNA levels in the uninjected control condition. SP-C mRNA levels in lung tissue of fetuses from both saline-injected and betamethasone-injected pregnant does were increased similarly, approximately twofold, over SP-C mRNA levels in fetal lung tissue obtained from uninjected control does. These data are suggestive that betamethasone treatment increases fetal lung SP-A and SP-B mRNA levels and that maternal stress alone can increase the expression of SP-B and SP-C mRNA in rabbit fetal lung tissue. Using in situ hybridization, SP-A mRNA was shown to be present primarily in alveolar type II cells in fetuses of control and saline-injected does. However, SP-A mRNA was easily detected in both alveolar type II cells and bronchiolar epithelial cells of rabbit fetal lung tissue following maternal betamethasone treatment. In contrast, SP-B and SP-C mRNA were present only in alveolar type II cells of lung tissue obtained from fetuses of control, saline, or betamethasone-treated does. Thus maternal administration of glucocorticoids increased SP-A protein as well as SP-A and SP-B mRNA levels in rabbit fetal lung tissue. SP-A mRNA was localized to both alveolar type II cells and in smaller amounts in bronchiolar epithelial cells of rabbit fetal lung tissue. However, SP-B and SP-C mRNA were detected only in alveolar type II cells.
在妊娠27天的兔胎儿肺组织中,研究了母体给予合成糖皮质激素倍他米松对表面活性物质蛋白SP - A、SP - B和SP - C的mRNA水平以及SP - A蛋白水平的影响。与生理盐水处理或未注射的动物所产胎儿相比,给怀孕兔子注射倍他米松后,胎儿肺中SP - A蛋白水平约增加两倍,胎儿肺中SP - A mRNA水平增加三倍。与未注射的怀孕母兔所产胎儿相比,糖皮质激素处理的怀孕母兔所产胎儿肺组织中SP - B mRNA增加四倍。然而,与未注射对照条件下胎儿肺SP - B mRNA水平相比,生理盐水注射对照组胎儿肺组织中的SP - B mRNA水平也显著升高,约两倍。生理盐水注射和倍他米松注射的怀孕母兔所产胎儿肺组织中的SP - C mRNA水平,与未注射对照母兔所产胎儿肺组织中的SP - C mRNA水平相比,同样增加了约两倍。这些数据表明,倍他米松处理可增加胎儿肺中SP - A和SP - B mRNA水平,且仅母体应激就能增加兔胎儿肺组织中SP - B和SP - C mRNA的表达。通过原位杂交显示,对照和生理盐水注射母兔所产胎儿的SP - A mRNA主要存在于II型肺泡细胞中。然而,母体给予倍他米松处理后,兔胎儿肺组织的II型肺泡细胞和细支气管上皮细胞中均能轻易检测到SP - A mRNA。相比之下,SP - B和SP - C mRNA仅存在于对照、生理盐水或倍他米松处理母兔所产胎儿的肺组织II型肺泡细胞中。因此,母体给予糖皮质激素可增加兔胎儿肺组织中SP - A蛋白以及SP - A和SP - B mRNA水平。SP - A mRNA定位于兔胎儿肺组织的II型肺泡细胞以及少量的细支气管上皮细胞中。然而,仅在II型肺泡细胞中检测到SP - B和SP - C mRNA。